Search

everythinglearnresearchcommunity

for

Search:↓

Lamivudine might reverse hair graying and needs more research for potential treatments.

Dermatologists in Western Rajasthan often prescribe doxepin for elderly patients with skin and mental health issues.

A man developed skin issues from cancer medication, which improved with specific treatments.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

PCOS increases the risk of heart disease and type 2 diabetes in women.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Lasers are effective and safe for various medical treatments, including cancer, wound healing, and skin conditions.

Female hair loss patients more likely to have dry eye and gland issues.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Isotretinoin can cause serious birth defects and needs careful use, especially in pregnant women.

Cannabidiol shows promise as an effective treatment for acne.

Hydroxychloroquine may help delay skin damage in lupus patients.

P144® improves hypertrophic scars by reducing size and thickness and increasing elasticity.

The review concluded that reporting on PRP therapy is often incomplete, leading to uncertainty about its effectiveness.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Soy supplements improve various skin conditions and aging signs, with topical use boosting skin barrier function.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

There is not enough evidence to know if different ways of putting in eye drops for glaucoma work better than others.

Substances from fat-derived stem cells can promote hair growth and counteract hormone-related hair loss by activating a key hair growth pathway.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.